Compass Ion Advisors »

Akebia Therapeutics shares owned by Compass Ion Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Compass Ion Advisors from 13F filings

Historical chart of Compass Ion Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Compass Ion Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Compass Ion Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $46k 25k 1.83

More positions owned by Compass Ion Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Core Div Grwth (DGRO)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Etf Ser Solutions Aptus Defined (DRSK)
Microstrategy Cl A New (MSTR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VB)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for Compass Ion Advisors

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Susquehanna International
Millennium Management
Jacobs Levy Equity Management
Federated Investors
Assenagon Asset Management
Connor, Clark & Lunn Investment Management
Citadel Advisors
Citigroup
Bank of America Corporation
Sapient Capital
Two Sigma Investments
Russell Investments
Two Sigma Advisers

View all funds holding Akebia Therapeutics